| Literature DB >> 15194783 |
Todd M Allen1, Marcus Altfeld, Xu G Yu, Kristin M O'Sullivan, Mathias Lichterfeld, Sylvie Le Gall, Mina John, Bianca R Mothe, Paul K Lee, Elizabeth T Kalife, Daniel E Cohen, Kenneth A Freedberg, Daryld A Strick, Mary N Johnston, Alessandro Sette, Eric S Rosenberg, Simon A Mallal, Philip J R Goulder, Christian Brander, Bruce D Walker.
Abstract
Numerous studies now support that human immunodeficiency virus type 1 (HIV-1) evolution is influenced by immune selection pressure, with population studies showing an association between specific HLA alleles and mutations within defined cytotoxic T-lymphocyte epitopes. Here we combine sequence data and functional studies of CD8 T-cell responses to demonstrate that allele-specific immune pressures also select for mutations flanking CD8 epitopes that impair antigen processing. In persons expressing HLA-A3, we demonstrate consistent selection for a mutation in a C-terminal flanking residue of the normally immunodominant Gag KK9 epitope that prevents its processing and presentation, resulting in a rapid decline in the CD8 T-cell response. This single amino acid substitution also lies within a second HLA-A3-restricted epitope, with the mutation directly impairing recognition by CD8 T cells. Transmission of the mutation to subjects expressing HLA-A3 was shown to prevent the induction of normally immunodominant acute-phase responses to both epitopes. However, subsequent in vivo reversion of the mutation was coincident with delayed induction of new CD8 T-cell responses to both epitopes. These data demonstrate that mutations within the flanking region of an HIV-1 epitope can impair recognition by an established CD8 T-cell response and that transmission of these mutations alters the acute-phase CD8(+) T-cell response. Moreover, reversion of these mutations in the absence of the original immune pressure reveals the potential plasticity of immunologically selected evolutionary changes.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15194783 PMCID: PMC421658 DOI: 10.1128/JVI.78.13.7069-7078.2004
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103